Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

Phase 1 Terminated 19 enrolled Genmedica Therapeutics S.L. Simbec Research · collab

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the toxicity, tolerability and safety of single ascending doses of GMC-252-L-Lysine Salt in healthy male subjects.

Timeline

Start: 2012-09
Primary completion: 2013-07
Completion: 2014-04

Outcome

Outcome not reported

Stopped (Business): “Business reason”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GMC-252	Unknown	—	Oral

Indications

No indication recorded.